CV Sciences (CVSI) Invested Capital (2010 - 2026)

CV Sciences has disclosed Invested Capital across 17 years of filings, most recently posting $1.6 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $1.6 million, down 41.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 41.02% YoY), and the FY2025 annual result was $2.7 million, up 10.44% from the prior year.
• Invested Capital came in at $1.6 million for Q1 2026 at CV Sciences, down from $2.7 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $5.7 million in Q1 2022 to a low of $948000.0 in Q4 2022.
• The 5-year median for Invested Capital is $2.7 million (2025), against an average of $2.8 million.
• Across the five-year window, Invested Capital plunged 87.75% in 2022 and jumped 206.22% in 2023, its largest moves.
• CV Sciences' Invested Capital stood at $948000.0 in 2022, then surged by 206.22% to $2.9 million in 2023, then declined by 14.85% to $2.5 million in 2024, then rose by 10.44% to $2.7 million in 2025, then tumbled by 42.49% to $1.6 million in 2026.
• The last three Invested Capital figures came in at $1.6 million (Q1 2026), $2.7 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.